Abstract:BACKGROUND AND OBJECTIVES Little is known about the effect of changes in dialysis hours on patient-reported outcome measures. We report the effect of doubling dialysis hours on a range of patient-reported outcome measures in a randomized trial, overall and separately for important subgroups. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS The A Clinical Trial of IntensiVE Dialysis trial randomized 200 participants to extended or standard weekly hours hemodialysis for 12 months. Patient-reported outcome measures included two health utility scores (EuroQOL-5 Dimensions-3 Level, Short Form-6 Dimension) and their derived quality-adjusted life year estimates, two generic health scores (Short Form-36 Physical Component Summary, Mental Component Summary), and a disease-specific score (Kidney Disease Component Score). Outcomes were assessed as the mean difference from baseline using linear mixed effects models adjusted for time point and baseline score, with interaction terms added for subgroup analyses. Prespecified subgroups were dialysis location (home- versus institution-based), dialysis vintage (≤6 months versus >6 months), region (China versus Australia, New Zealand, Canada), and baseline score (lowest, middle, highest tertile). Multiplicity-adjusted P values (Holm-Bonferroni) were calculated for the main analyses. RESULTS Extended dialysis hours was associated with improvement in Short Form-6 Dimension (mean difference, 0.027; 95% confidence interval [95% CI], 0.00 to 0.05; P=0.03) which was not significant after adjustment for multiple comparisons (Padjusted =0.05). There were no significant differences in EuroQOL-5 Dimensions-3 Level health utility (mean difference, 0.036; 95% CI, -0.02 to 0.09; P=0.2; Padjusted =0.2) or in quality-adjusted life years. There were small positive differences in generic and disease-specific quality of life: Physical Component Summary (mean difference, 2.3; 95% CI, 0.6 to 4.1; P=0.01; Padjusted =0.04), Mental Component Summary (mean difference, 2.5; 95% CI, 0.5 to 4.6; P=0.02; Padjusted =0.05) and Kidney Disease Component Score (mean difference, 3.5; 95% CI, 1.5 to 5.5; P=0.001; Padjusted =0.005). The results did not differ among predefined subgroups or by baseline score. CONCLUSIONS The effect of extended hours hemodialysis on patient-reported outcome measures reached statistical significance in some but not all measures. Within each measure the effect was consistent across predefined subgroups. The clinical importance of these differences is unclear.

Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis.

Twice-Weekly Hemodialysis and Clinical Outcomes in the China Dialysis Outcomes and Practice Patterns Study

High-risk end-stage renal disease patients converted from conventional to short daily haemodialysis.

Clinical Outcome of Twice-Weekly Hemodialysis Patients in Shanghai

Effects of Kt/Vurea on outcomes according to age in patients on maintenance hemodialysis

The Nitty-Gritties of Kt/Vurea Calculations in Hemodialysis and Peritoneal Dialysis

Supplementary Material For: Association of Initial Twice-Weekly Hemodialysis Treatment with Preservation of Residual Kidney Function in ESRD Patients

Twice-weekly and Incremental Hemodialysis Treatment for Initiation of Kidney Replacement Therapy.

Once upon a time in dialysis: the last days of Kt/V?

The Patient's Perspective: Does It Align with Dialysis Adequacy?

Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review

The investigation of standard deviation of Kt/V(δKt/V)as an important indicator for the evaluation of general clinical conditions of chronic maintenance hemodialysis patients

Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.

Effects of hemodialysis adequacy on chronic kidney disease complications using latent class trajectory modeling: a real-world study based on long-term observation of Kt/V

Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trials

Primary Clinical Experience in High Risk Uremic Patients Converted from Conventional to Short Daily Hemodialysis

Incremental hemodialysis transition in veterans and nonveterans with kidney failure

Adequacy of Dialysis and Incidence of Atrial Fibrillation in Patients Undergoing Hemodialysis

Research progress on measurement methods and evaluation of the hemodialysis adequacy index Kt/V

The relationship between standard deviation of Kt/V(б_(Kt/V)) and systolic,diastolic and the mean blood pressure of chronic maintenance hemodialysis patiants

Varying Association of Extended Hours Dialysis with Quality of Life.